ONWRF (Onward Medical NV) Moat Score: 3/10 (As of Jul. 05, 2026)


ONWRF Onward Medical NV ONWRF
37 GF Score
Price $2.94
GF Value $155.17
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Onward Medical NV Moat Score?

Onward Medical NV ONWRF 37 Moat Score is 3 as of Jul. 05, 2026. GuruFocus rates ONWRF with a GF Score™ of 37/100 and a GF Value™ of $155.17 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 1,395 Biotechnology companies, Onward Medical NV ranks better than 75.48% on this metric.

Onward Medical NV has the Moat Score of 3, which implies that the company might have No Moat - Very weak/transient advantages.

Onward Medical NV has No Moat: Onward Medical NV operates in a competitive medical technology space with limited market leadership and no significant network effects or customer switching costs. The company lacks strong brand strength, durable cost advantages, or significant regulatory barriers. Its intellectual property and innovation capabilities are not sufficient to establish a sustainable competitive advantage.

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Onward Medical NV might have No Moat - Very weak/transient advantages.

Onward Medical NV  (OTCPK:ONWRF) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Onward Medical NV Moat Score Related Terms

ONWRF vs VRTX, REGN, ALNY: Moat Score Comparison

For the Biotechnology subindustry, Onward Medical NV's Moat Score, along with its competitors' market caps and Moat Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Onward Medical NV Moat Score vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Onward Medical NV's Moat Score distribution charts can be found below:

* The bar in red indicates where Onward Medical NV's Moat Score falls into.


ONWRF
37GF Score
Onward Medical NV ONWRF
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Moat Score →
What does a Moat Score of 3 mean?
Onward Medical NV (ONWRF) has a Moat Score of 3 as of Jul. 05, 2026. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. According to the industry distribution chart, Onward Medical NV ranks #342 out of 1395 companies in the Biotechnology industry, placing it in the top 24.5%.
Is Onward Medical NV's Moat Score too high?
Onward Medical NV's current Moat Score is 3. The Biotechnology industry median Moat Score is 2.00. Onward Medical NV's value of 3 is 50% above this industry median. Based on the distribution chart, Onward Medical NV ranks #342 out of 1395 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Onward Medical NV has a GF Score™ of 37/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Onward Medical NV's Moat Score compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Onward Medical NV ranks #342 out of 1395 companies for Moat Score. This places Onward Medical NV in the top 25% of its industry — outperforming the majority of peers. The industry median Moat Score is 2.00. Onward Medical NV's value of 3 is 50% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Moat Score for a Biotechnology company?
The median Moat Score among Biotechnology companies is 2.00, based on 1,395 companies in the industry. Companies in the top quartile (top 25%) have a Moat Score significantly above this median, while those in the bottom quartile fall well below. However, Moat Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Onward Medical NV's current Moat Score of 3 is 50% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Moat Score mean?
A high Moat Score can signal that a stock is expensive relative to its fundamentals. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. For the Biotechnology industry, the median Moat Score is 2.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Onward Medical NV's current Moat Score is 3. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Onward Medical NV stock overvalued right now?
Based on GuruFocus' analysis, Onward Medical NV (ONWRF) is currently considered Possible Value Trap. The stock's GF Value™ is $155.17, compared to a current price of $2.94 — trading 98.1% below its estimated fair value. The current Moat Score is 3 and 50% above the Biotechnology industry median of 2.00. Onward Medical NV's overall GF Score™ is 37/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Moat Score calculated?
Moat Score is calculated from a company's financial statements. For Onward Medical NV (ONWRF), the current Moat Score is 3 as of Jul. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Onward Medical NV (ONWRF) Overvalued in 2026?

Based on GuruFocus' analysis, Onward Medical NV stock appears to be undervalued. The current stock price of $2.94 is trading 98.1% below its estimated GF Value™ of $155.17. GuruFocus considers Onward Medical NV to be Possible Value Trap.

Key valuation signals for ONWRF:

  • Moat Score: 3
  • GF Value™: $155.17 vs. price of $2.94 (98.1% below fair value)
  • GF Score™: 37/100 with 4 warning signs
  • Industry Position: 50% above the Biotechnology median (#342 of 1395)

No single metric tells the full story. See the ONWRF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Onward Medical NV Business Description

Other Exchanges 63E:GermanyONWD:Belgium
Address Schimmelt 2, Eindhoven, NH, NLD, NL-5656
Onward Medical NV is developing and commercializing therapies to enable functional recovery for people with Spinal Cord Injury (SCI). The company's technology platforms are based on ONWARD ARC Therapy (ARC Therapy), targeted, programmed electrical stimulation of the spinal cord designed to restore movement, independence, and health in people with SCI.
37GF Score

Get the complete analysis for ONWRF

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.94
Price
$155.17
GF Value